Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anaptysbio (ANAB) Return on Invested Capital (2018 - 2025)

Anaptysbio (ANAB) has disclosed Return on Invested Capital for 6 consecutive years, with 0.71% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Invested Capital rose 77.0% year-over-year to 0.71%, compared with a TTM value of 0.71% through Dec 2025, up 77.0%, and an annual FY2025 reading of 0.05%, up 139.0% over the prior year.
  • Return on Invested Capital was 0.71% for Q4 2025 at Anaptysbio, down from 0.77% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 16.09% in Q2 2025 and bottomed at 5.63% in Q2 2024.
  • Average Return on Invested Capital over 3 years is 0.0%, with a median of 1.58% recorded in 2023.
  • The sharpest move saw Return on Invested Capital grew 10bps in 2024, then skyrocketed 2172bps in 2025.
  • Year by year, Return on Invested Capital stood at 1.58% in 2023, then rose by 6bps to 1.48% in 2024, then surged by 52bps to 0.71% in 2025.
  • Business Quant data shows Return on Invested Capital for ANAB at 0.71% in Q4 2025, 0.77% in Q3 2025, and 16.09% in Q2 2025.